The Egyptian Journal of Otolaryngology (Jul 2022)

The goal of primary therapy in non-metastatic nasopharyngeal cancer should be radiological complete response

  • Mustafa Korkmaz,
  • Melek Karakurt Eryılmaz,
  • Mehmet Zahid Koçak,
  • Aykut Demirkıran,
  • Mustafa Karaağaç,
  • Mehmet Artaç

DOI
https://doi.org/10.1186/s43163-022-00267-1
Journal volume & issue
Vol. 38, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Background We aimed to investigate the effect of radiological complete response on survival outcomes in patients with non-metastatic nasopharyngeal cancer. This study is conducted as a retrospective cohort. Of the 185 patients screened, 60 were metastatic, 25 patients’ data was not available, and as a result, 92 patients were included in the study. Among the complete response (CR) and incomplete response (IR) groups, overall survival (OS), distant metastasis-free survival (DMFS), and locoregional failure-free survival (LRFFS) were evaluated. Results Of the 92 patients, 54 (58.6%) were CR and 38 (41.4%) were IR patients. Of the whole study group, the 5-year OS, DMFS, and LRFFS rates were 75%, 78%, and 95%, respectively. A significant difference was found between the 5-year OS (90% vs. 60%, p = 0.001) and DMFS (87% vs. 65%, p = 0.02) rates. However, there was no significant difference in the 5-year LRFFS rate (97% vs. 92%, p = 0.16). Complete response were determined as an independent predictor for OS (HR: 0.13, 95% Cl: 0.045–0.36, p < 0.001) and DMFS (HR: 0.26, 95% CI: 0.095–0.744, p = 0.012). Conclusion As a result, the survival benefit in patients with CR after primary treatment is evident as shown in the above studies. Therefore, the aim of primary treatment should be to increase the CR rates. It is important to evaluate early tumor response to determine poor tumor regression.

Keywords